Image-Guided Nanoparticle-Based siRNA Delivery for Cancer Therapy

Area of Science:

• Biotechnology
• Nanotechnology
• Molecular Imaging

Background:

• RNA interference (RNAi) technology, utilizing small interfering RNA (siRNA), presents a potent strategy for targeted gene therapy due to its specificity.
• A significant hurdle in gene therapy is the lack of real-time monitoring of therapeutic agent delivery and treatment response at the target site.

Purpose of the Study:

• To explore the integration of molecular imaging with gene therapy for enhanced treatment efficacy.
• To review advancements in nanotechnology for developing multifunctional nanoparticles capable of simultaneous imaging and siRNA delivery for image-guided therapy.

Main Methods:

• Overview of polymer and lipid-based nanocarriers designed for siRNA delivery.
• Integration of imaging agents within nanocarrier systems for image-guided therapeutic applications.

Main Results:

• Nanoparticles function as contrast agents for disease detection and simultaneously deliver therapeutic siRNA.
• This approach enables monitoring of drug accumulation and assimilation, facilitating treatment response evaluation.

Conclusions:

• Multifunctional nanoparticles offer a promising platform for image-guided therapy, addressing the monitoring limitations in siRNA-based gene therapy.
• This strategy holds potential for treating various cancers, including breast, lung, liver, ovarian, cervical, and prostate cancers.